STAT

STAT+: AbbVie Parkinson’s drug helps improve symptoms in late-stage study

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

AbbVie reported Thursday that its experimental Parkinson’s drug that it got from Cerevel Therapeutics helped alleviate symptoms and improve quality of life in a late-stage study.

In the Phase 3 trial, early-stage Parkinson’s patients on the highest dose of the drug, called tavapadon, experienced a 10.2-point improvement on tests that measured motor symptoms and quality of life, also known as the MDS-UPDRS parts II and III. Meanwhile, those on placebo saw a 1.8-point worsening.

Continue to STAT+ to read the full story…

6 months 3 weeks ago

Biotech, biotechnology, chronic disease, STAT+

Healio News

Cats associated with reduced odds for childhood asthma

Children in Puerto Rico who grew up with a cat in their household were 68% less likely to develop asthma, according to a study published in Annals of Allergy, Asthma & Immunology.However, there were no associations between dogs and asthma, Yueh-Ying Han, PhD, MS, research associate professor of pediatrics, division of pulmonary medicine, department of pediatrics, UPMC Children’s Hospital of

Pittsburgh, University of Pittsburgh, and colleagues wrote.“Although pet ownership has been associated with allergic diseases such as asthma, the evidence is inconsistent, partly due to

6 months 3 weeks ago

Health News Today on Fox News

Apple Watch could help you uncover hidden sleep apnea

Do you often wake up feeling exhausted, even after a full night's sleep? You might be one of the millions of people unknowingly living with sleep apnea. But here's some great news.

Do you often wake up feeling exhausted, even after a full night's sleep? You might be one of the millions of people unknowingly living with sleep apnea. But here's some great news. Apple has just introduced a game-changing feature that could help you identify this hidden health issue right from your wrist.

If you own an Apple Watch Series 10, 9 or Ultra 2, you'll soon have a personal sleep detective on your arm. This new feature uses the watch's built-in technology to monitor your breathing patterns while you sleep, looking for signs that could indicate sleep apnea. 

No more need for complicated sleep studies or expensive equipment; your everyday smartwatch could be the key to uncovering this common but often undiagnosed condition.

GET SECURITY ALERTS, EXPERT TIPS – SIGN UP FOR KURT’S NEWSLETTER – THE CYBERGUY REPORT HERE

The sleep apnea detection feature utilizes the watch's built-in accelerometer to monitor a new metric called "breathing disturbances" during sleep. By analyzing these disturbances over time, the watch can identify patterns consistent with moderate to severe sleep apnea.

APPLE TRANSFORMS AIRPODS PRO 2 INTO LOW-COST HEARING AIDS

The U.S. Food and Drug Administration (FDA) has granted approval for this sleep apnea feature, marking a significant milestone in wearable health technology. Apple plans to roll out the functionality to more than 150 countries and regions this month, including the United States, Europe and Japan.

APPLE'S BOLD MOVE INTO AI: NEW IPHONE 16, AIRPODS AND WATCHES

You can view your nightly breathing disturbance data in the Health app on your iPhone, where it will be categorized as either "elevated" or "not elevated." The watch analyzes this data over a 30-day period and notifies users if it detects consistent signs of sleep apnea.

IOS 18: DISCOVER THE NEW FEATURES IN APPLE'S LATEST OPERATING SYSTEM

In clinical validation studies, the notification performance achieved a sensitivity of 66.3% and specificity of 98.5%. This means that while the algorithm is effective at identifying those with moderate to severe sleep apnea, it also minimizes false positives, ensuring that you can trust the notifications you receive.

HOW TO REMOVE YOUR PRIVATE DATA FROM THE INTERNET 

TOP SLEEP ACCESSORIES 2024

Dr. Sumbul Desai, Apple's vice president of health, emphasized the rigorous development process behind this feature. The detection algorithm was created using advanced machine learning with extensive datasets from clinical-grade sleep apnea tests. The studies included diverse participants across various demographics and evaluated both at-home and in-lab sleeping environments.

This new feature has the potential to significantly impact public health by helping identify undiagnosed cases of sleep apnea. Research suggests that up to 80% of sleep apnea cases remain undiagnosed, making this tool invaluable for many people who may not exhibit obvious symptoms.

THE HIDDEN COSTS OF FREE APPS: YOUR PERSONAL INFORMATION

To use the new sleep apnea detection feature on your Apple Watch, follow these steps:

Ensure your Apple Watch is running the latest version of watchOS. Here are the steps:

Update your iPhone to the latest iOS version. Here are the steps:

Remember, this feature is designed for users 18 years or older who have not been diagnosed with sleep apnea. If you receive a notification suggesting signs of sleep apnea, it's important to consult with your health care provider for proper evaluation and diagnosis.

SUBSCRIBE TO KURT’S YOUTUBE CHANNEL FOR QUICK VIDEO TIPS ON HOW TO WORK ALL OF YOUR TECH DEVICES

It’s incredible how technology can empower us to take charge of our health, and the new sleep apnea detection feature on the Apple Watch 10, 9 and Ultra 2 is a perfect example. With this tool, you can monitor your breathing patterns while you sleep, potentially uncovering issues that have gone unnoticed for far too long. Just remember, while this feature is a fantastic step toward better health, it’s essential to consult with a health care provider if you receive a notification about possible sleep apnea. Embracing these advancements could lead to a more restful night and a healthier life.

How do you feel about using wearable technology like the Apple Watch for health monitoring? Are you excited about these advancements, or do you have concerns about privacy and accuracy? Let us know by writing us at Cyberguy.com/Contact.

For more of my tech tips and security alerts, subscribe to my free CyberGuy Report Newsletter by heading to Cyberguy.com/Newsletter.

Ask Kurt a question or let us know what stories you'd like us to cover.

Follow Kurt on his social channels:

Answers to the most asked CyberGuy questions:

New from Kurt:

Copyright 2024 CyberGuy.com. All rights reserved.

6 months 3 weeks ago

tech, innovation, apple, iphone, lifestyle, fitness-and-wellbeing, Health

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Medical bulletin 26/ September/ 2024

Here are the top medical news for the day:

How Do Initial Symptoms of MS Have Impact on Long Run Disability?

Here are the top medical news for the day:

How Do Initial Symptoms of MS Have Impact on Long Run Disability?

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research was published in the latest issue of Brain Medicine (Genomic Press, New York)Led by Dr. João Pedro F. Gonçalves from the Federal University of Bahia, Brazil, the study analyzed data from 195 multiple sclerosis patients, focusing on their symptoms at disease onset and subsequent functional outcomes. The team's findings challenge some previously held beliefs about multiple sclerosis progression and open up new avenues for personalized treatment approaches."Our research indicates that patients who experience acute blurry vision or sphincter dysfunction when first diagnosed with multiple sclerosis may be at higher risk for developing more severe disability over time," explains Dr. Gonçalves. "This information could be crucial for healthcare providers in determining initial treatment strategies and monitoring protocols."Key findings of the study include:- Patients presenting with acute blurry vision at onset had 20% higher odds of worse functional outcomes.- Those experiencing sphincter dysfunction (such as bladder or bowel issues) at onset had 24.5% higher odds of developing more severe disability.- Contrary to some previous studies, symptoms like acute paralysis and hypoesthesia were not independent predictors of worse outcomes in the long term.The study utilized the Expanded Disability Status Scale (EDSS), a widely recognized tool for quantifying disability in multiple sclerosis patients. This approach allowed the researchers to correlate initial symptoms with long-term functional status objectively.The findings prompt consideration of how this knowledge might be integrated into current multiple sclerosis treatment guidelines. The study also highlights the complex interplay between various multiple sclerosis symptoms and their impact on patient’s quality of life. While some symptoms like acute paralysis might seem more severe initially, the research suggests that less obvious issues like blurry vision or bladder dysfunction could be more predictive of long-term challenges. "These findings could potentially reshape how we approach initial MS treatment decisions," notes Dr. Gonçalves. "By identifying patients at higher risk for severe disability early on, we may be able to intervene more aggressively and potentially alter the disease course."Reference: " The association of different acute manifestations of multiple sclerosis on functional outcome " will be published in Brain Medicine on September 24, 2024. It will be freely available online at https://bm.genomicpress.com/aop/Are You at Risk? New Study Reveals Hidden Cancer Dangers in Your GenesResearchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and breast cancer, opening the door to more accurate risk assessment and individualized treatment. With a focus on the "cancer protection" gene RAD51C, researchers from the Wellcome Sanger Institute and their partners discovered over 3,000 deleterious genetic alterations that may interfere with its function and raise the risk of aggressive subtypes of breast cancer four times as well as ovarian cancer six times. Data analysis from extensive health databases validated these conclusions.The results, can be utilized right away to assist medical professionals and diagnostic laboratory scientists in more accurately estimating the risk of cancer, particularly in those with a family history of malignancies.The study also identified regions of the protein essential for its function, pointing to new roles in cancer development and potential therapeutic targets.The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, if there are two harmful gene changes are present, may result in Fanconi Anaemia, a severe genetic disorder. Women with a faulty RAD51C gene face a 15 to 30 per cent lifetime risk of developing breast cancer and a 10 to 15 per cent risk of developing ovarian cancer.In this new study, researchers from the Wellcome Sanger Institute and their collaborators set out to understand the effect of 9,188 unique changes in the RAD51C gene by artificially altering the genetic code of human cells grown in a dish, in a process known as 'saturation genome editing'. They identified 3,094 of these variants that may disrupt the gene's function and increase cancer risk, with an accuracy above 99.9 per cent when compared to clinical data.By mapping the protein structure, the team also identified crucial surface areas of RAD51C essential for its DNA repair function. These regions may interact with other, yet-to-be-identified proteins or play a role in processes such as phosphorylation, offering valuable insights for drug development and potential new treatment targets.The study also revealed the existence of 'hypomorphic alleles' - a type of variant that reduces the RAD51C gene's function without completely disabling it. These appear to be more common than previously thought and may significantly contribute to breast and ovarian cancer risk.Rebeca Olvera-Leon, first author of the study at the Wellcome Sanger Institute, said: "This research demonstrates that genetic risk for breast and ovarian cancer isn't a simple yes-or-no scenario, but exists on a spectrum based on how genetic changes affect protein function. With a more comprehensive understanding of how RAD51C genetic variants contribute to cancer risk, this opens up new possibilities for more accurate risk prediction, prevention strategies, and potentially targeted therapies."Dr Andrew Waters, co-senior author of the study at the Wellcome Sanger Institute, said: "This work demonstrates the power of analysing genetic variants on a large scale within their genomic context. Not only can we understand how cancer-related DNA changes affect patients, helping with clinical decisions, but we can also explore how these variants impact the gene's function at a detailed molecular level. This provides important insights into how proteins work and how genes evolve over time."Reference: Olvera-León, R., Zhang, F., Offord, V., Zhao, Y., Tan, H. K., Gupta, P., ... & Adams, D. J. (2024). High-resolution functional mapping of RAD51C by saturation genome editing. Cell.Magnesium Sulphate Infusion May Prevent Cerebral Palsy in Premature Babies: Cochrane ReviewGiving women at risk of premature birth a simple magnesium sulphate infusion (or ‘drip’) can prevent their babies from developing cerebral palsy, a recent Cochrane review has confirmed. A new editorial calls for this intervention to be implemented more widely and equitably, as it is still not consistently available worldwide.“Preterm birth is the leading cause of brain injury and cerebral palsy with lifelong impact on children and families,” says Karen Luyt, Professor in Neonatal Medicine at the University of Bristol. “When the Cochrane meta-analysis was published in 2009, I realised that magnesium sulphate, given to mothers in preterm labour, was a potential game changer. The first effective neuroprotective treatment for preterm babies, preventing cerebral palsy by around 30%. We were early adopters at St Michael’s Hospital (University Hospitals Bristol & Weston NHS Trust).Following correspondence with the Cochrane authors, Karen began implementing the findings in her own hospital through a programme called PReCePT (prevention of cerebral palsy in pre-term labour). Supported by Health Innovation West of England and co-designed by parents and maternity ward staff, the programme provides practical tools and training to ensure eligible mothers are offered magnesium sulphate.The widespread use of this life-changing treatment was made possible by the original Cochrane review led by Professors Lex Doyle and Caroline Crowther, published in 2009.Karen worked alongside clinicians around the world to develop materials to help people in lower-resource settings to implement magnesium sulphate alongside other interventions to help premature babies. In her new editorial in the Cochrane Library, she urges increased global uptake and implementation research in lower-resource settings.“Reference: Shepherd, E. S., Goldsmith, S., Doyle, L. W., Middleton, P., Marret, S., Rouse, D. J., ... & Crowther, C. A. (2024). Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews, (5).High Sensitivity Troponin Test Demonstrates Better Diagnostic Accuracy in Acute Coronary Syndrome Cases: Systematic Review RevealsHigh sensitivity troponin shows promise in diagnosing acute coronary syndrome in primary care settings. The findings were published in the Annals of Family Medicine.Chest pain can be caused by both serious conditions and more benign issues. The present study assessed the effectiveness of various risk stratification tools, including clinical decision rules and troponin tests, in helping general practitioners rule out acute coronary syndrome in patients with chest pain.Researchers conducted a systematic review of studies involving adult patients presenting with chest pain in primary care settings. The review included studies that examined the diagnostic accuracy of different clinical decision rules and troponin point-of-care tests, both conventional and high-sensitivity, in identifying acute coronary syndrome, which includes heart attacks. The study compared these tools to the unaided clinical judgment of general practitioners.14 studies were included in the final review.• Some of the clinical decision rules without troponin improved safety. However, none consistently outperformed unaided general practitioner judgment in ruling out acute coronary syndrome.• Conventional troponin as a standalone test did not meet the desired diagnostic accuracy, making the tests less reliable in primary care settings.• High-sensitivity troponin tests demonstrated the highest diagnostic accuracy. However, this finding requires further prospective validation in primary care before it can be recommended for widespread use.Although high-sensitivity troponin tests hold promise, they are not yet ready to replace clinical judgment or be used independently in primary care settings without further validation.Reference: van den Bulk, S., Manten, A., Bonten, T. N., & Harskamp, R. E. (2024). Chest pain in primary care: A systematic review of risk stratification tools to rule out acute coronary syndrome. The Annals of Family Medicine, 22(5), 426-436. https://doi.org/10.1370/afm.3141

6 months 3 weeks ago

MDTV,Channels - Medical Dialogues,Medical News Today MDTV,Medical News Today

KFF Health News

In Montana Senate Race, Democrat Jon Tester Misleads on Republican Tim Sheehy’s Abortion Stance

Tim Sheehy “would let politicians like him ban abortion, with no exceptions for rape or to save a woman’s life, and criminalize women.”

A Facebook ad from the campaign of Sen. Jon Tester (D-Mont.), launched on Sept. 6, 2024

Tim Sheehy “would let politicians like him ban abortion, with no exceptions for rape or to save a woman’s life, and criminalize women.”

A Facebook ad from the campaign of Sen. Jon Tester (D-Mont.), launched on Sept. 6, 2024

In a race that could decide control of the U.S. Senate, Sen. Jon Tester (D-Mont.) is attacking his challenger, Republican Tim Sheehy, for his stance on abortion. 

Montana’s Senate race is one of a half-dozen tight contests around the country in which Democrats are defending seats needed to keep their one-seat majority. If Republicans flip Tester’s seat, they could take over the chamber even if they fail to oust Democrats in any other key races.

In a series of Facebook ads launched in early September, Tester’s campaign said Sheehy supports banning abortion with no exceptions.

An ad launched on Sept. 6 said, “Tim Sheehy wants to take away the freedom to choose what happens with your own body, and give that power to politicians. Sheehy would let politicians like him ban abortion, with no exceptions for rape or to save a woman’s life, and criminalize women. We can’t let Tim Sheehy take our freedom away.”

Sheehy’s Anti-Abortion Stance Allows for Rape, Health Exceptions

Sheehy’s website calls him “proudly pro-life,” and he’s campaigning against abortion. He opposes a measure on Montana’s November ballot that would amend the Montana Constitution to provide the right to “make and carry out decisions about one’s own pregnancy, including the right to abortion.”

In July, we rated False Sheehy’s statement that Tester and other Democrats have voted for “elective abortions up to and including the moment of birth. Healthy, 9-month-year-old baby killed at the moment of birth.”

But contrary to the new ad’s message, Sheehy has voiced support for exceptions.

In a Montana Public Radio interview in May, Sheehy was asked, “Yes or no, do you support a federal ban on abortion?” 

Sheehy said, “I am proudly pro-life and support commonsense protections for when a baby can feel pain, as well as exceptions for rape, incest, and the life of the mother, and I believe any further limits must be left to each state.”

And in a June debate with Tester, Sheehy said, “I’ll always protect the three rights for women: rape, incest, life of the mother.”

The issues section of Sheehy’s campaign website does not say that he has a no-exceptions stance, nor does it say he would “criminalize women” who have abortions.

In a statement, the Sheehy campaign told PolitiFact that the ad mischaracterizes Sheehy’s abortion position. Allowing no exceptions “has never been Tim’s position,” the campaign said.

Our Ruling

The Tester campaign’s ad says Sheehy “would let politicians like him ban abortion, with no exceptions for rape or to save a woman’s life, and criminalize women.” 

Sheehy has said he supports abortion ban exceptions for rape or to save a pregnant woman’s life. We found no instances of him saying he would be OK with states criminalizing women who receive abortions in violation of state laws.

What gives the ad a kernel of truth is that Sheehy has voiced support for letting states decide abortion parameters within their borders. The Tester campaign argues that this means Sheehy would effectively enable legislators to pass abortion restrictions that don’t include exceptions or that criminalize women.

The Tester campaign’s argument relies on hypotheticals and ignores Sheehy’s stated support for exceptions, giving a misleading impression of Sheehy’s position.

We rate it Mostly False.

Our Sources

Jon Tester, Facebook ad, Sept. 6, 2024

Tim Sheehy, campaign issues page, accessed Sept. 12, 2024

KFF, “Policy Tracker: Exceptions to State Abortion Bans and Early Gestational Limits,” last updated July 29, 2024

Montana Public Radio, “Q&A: Tim Sheehy, Republican Candidate for U.S. Senate,” May 15, 2024 

Montana Senate debate (excerpt), June 9, 2024

Last Best Place PAC, “choice” web page, accessed Sept. 12, 2024

Montana Republican Party, 2024 platform, accessed Sept. 12. 2024

Daily Montanan, “Sheehy criticizes ballot measures, including initiative to protect abortion,” Aug. 22, 2024

Sabato’s Crystal Ball, “Where Abortion Rights Will (or Could) Be on the Ballot,” July 9, 2024

Heartland Signal, “Unearthed audio shows Tim Sheehy calling abortion ‘sinful,’ wanting it to ‘end tomorrow,’” Aug. 30, 2024

Montana Independent, “Jon Tester accuses Tim Sheehy of lying about abortion during first Senate campaign debate,” June 11, 2024

Statement to PolitiFact from the Sheehy campaign

Statement to PolitiFact from the Tester campaign

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

6 months 3 weeks ago

States, Abortion, KFF Health News & PolitiFact HealthCheck, Montana, U.S. Congress, Women's Health

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

How Do Initial Symptoms of MS Impact Long-Run Disability? Study Sheds Light

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research was published in the latest issue of Brain Medicine (Genomic Press, New York)

Led by Dr. João Pedro F. Gonçalves from the Federal University of Bahia, Brazil, the study analyzed data from 195 multiple sclerosis patients, focusing on their symptoms at disease onset and subsequent functional outcomes. The team's findings challenge some previously held beliefs about multiple sclerosis progression and open up new avenues for personalized treatment approaches."Our research indicates that patients who experience acute blurry vision or sphincter dysfunction when first diagnosed with multiple sclerosis may be at higher risk for developing more severe disability over time," explains Dr. Gonçalves. "This information could be crucial for healthcare providers in determining initial treatment strategies and monitoring protocols."Key findings of the study include:- Patients presenting with acute blurry vision at onset had 20% higher odds of worse functional outcomes.- Those experiencing sphincter dysfunction (such as bladder or bowel issues) at onset had 24.5% higher odds of developing more severe disability.- Contrary to some previous studies, symptoms like acute paralysis and hypoesthesia were not independent predictors of worse outcomes in the long term.The study utilized the Expanded Disability Status Scale (EDSS), a widely recognized tool for quantifying disability in multiple sclerosis patients. This approach allowed the researchers to correlate initial symptoms with long-term functional status objectively.The findings prompt consideration of how this knowledge might be integrated into current multiple sclerosis treatment guidelines. The study also highlights the complex interplay between various multiple sclerosis symptoms and their impact on patient’s quality of life. While some symptoms like acute paralysis might seem more severe initially, the research suggests that less obvious issues like blurry vision or bladder dysfunction could be more predictive of long-term challenges. "These findings could potentially reshape how we approach initial MS treatment decisions," notes Dr. Gonçalves. "By identifying patients at higher risk for severe disability early on, we may be able to intervene more aggressively and potentially alter the disease course."Reference: " The association of different acute manifestations of multiple sclerosis on functional outcome " will be published in Brain Medicine on September 24, 2024. It will be freely available online at https://bm.genomicpress.com/aop/

6 months 3 weeks ago

Neurology and Neurosurgery,Neurology & Neurosurgery News,Top Medical News,Neurology and Neurosurgery Videos,MDTV,Neurology and Neurosurgery MDTV,MD shorts MDTV,Neurology & Neurosurgery Shorts,Channels - Medical Dialogues,Latest Videos MDTV,MD Shorts

PAHO/WHO | Pan American Health Organization

Director de la OPS destaca la importancia de una respuesta global solidaria y equitativa a la resistencia a los antimicrobianos

PAHO Director highlights importance of a global, solidarity-based and equitable response to antimicrobial resistance

Cristina Mitchell

25 Sep 2024

PAHO Director highlights importance of a global, solidarity-based and equitable response to antimicrobial resistance

Cristina Mitchell

25 Sep 2024

6 months 3 weeks ago

Healio News

VIDEO: Physicians ‘need to be involved’ in the regulation of AI in health care

AI has shown potential in health care applications, but there are some factors physicians should understand regarding its regulation, a speaker at the Osteopathic Medical Education Conference explained.Several efforts have previously been made to oversee AI utilization.

Last year, President Joe Biden issued an executive order for HHS to establish an AI task force that will aim to develop policies and frameworks on the responsible use of AI in the health and human services sector.“AI obviously is very promising — we are looking forward to a lot of innovation to help with patient

6 months 3 weeks ago

PAHO/WHO | Pan American Health Organization

PAHO and IDB sign agreement to broaden collaboration

PAHO and IDB sign agreement to broaden collaboration

Cristina Mitchell

25 Sep 2024

PAHO and IDB sign agreement to broaden collaboration

Cristina Mitchell

25 Sep 2024

6 months 3 weeks ago

Health – Dominican Today

Dominican Republic commits to achieving Universal Health Coverage by 2030

New York.- The Dominican Republic is actively working toward achieving Universal Health Coverage (UHC) by 2030 through initiatives such as the “Policy of Universal Access to Health and Social Security,” part of the government’s central strategy for 2025-2028.

New York.- The Dominican Republic is actively working toward achieving Universal Health Coverage (UHC) by 2030 through initiatives such as the “Policy of Universal Access to Health and Social Security,” part of the government’s central strategy for 2025-2028. During the “Ministerial Meeting of the Group of Friends of UHC and Global Health” at the UN, Minister of Health Victor Atallah emphasized that the country is focusing on ensuring the right to health for all, supported by adequate financial resources and efficient hospital management.

Atallah highlighted two key initiatives: the HEARTS strategy, aimed at preventing and controlling cardiovascular diseases by strengthening primary care, and a national strategy based on the One Health approach, addressing the interconnection between human, animal, and environmental health. He also mentioned efforts to combat antimicrobial resistance, zoonotic diseases, and plans to launch a “School Health” program in 2025, benefiting 2.2 million children and adolescents.

Despite progress, Atallah acknowledged challenges ahead but reaffirmed the Dominican Republic’s commitment to building inclusive and resilient health systems. The event, part of the 79th UN General Assembly, brought together health ministers and global leaders to discuss strengthening future health systems, and Atallah’s participation contributed to highlighting the country’s public health advances.

6 months 3 weeks ago

Health

Health

Malvern Health Centre reopens following $54m Operation Refresh upgrade

THE MALVERN Health Centre in St Elizabeth has been officially reopened following a comprehensive $54-million upgrade under the Ministry of Health and Wellness’ ‘Operation Refresh’ programme. Portfolio minister Dr Christopher Tufton reopened the...

THE MALVERN Health Centre in St Elizabeth has been officially reopened following a comprehensive $54-million upgrade under the Ministry of Health and Wellness’ ‘Operation Refresh’ programme. Portfolio minister Dr Christopher Tufton reopened the...

6 months 3 weeks ago

Health

Natural healing for anxiety, panic attacks

ANXIETY IS what we feel when we are worried, tense or afraid, particularly about things that are about to happen, or which we think could happen in the future. Anxiety is a natural human response when we feel that we are under threat. It can be...

ANXIETY IS what we feel when we are worried, tense or afraid, particularly about things that are about to happen, or which we think could happen in the future. Anxiety is a natural human response when we feel that we are under threat. It can be...

6 months 3 weeks ago

Health

Lifestyle interventions can slow or reverse some illnesses

HAVE YOU ever gone to the doctor and spent more time talking about how to treat your symptoms, rather than what is causing them? Have you been prescribed medications that merely mask your symptoms, or even make them worse? Addressing the root cause...

HAVE YOU ever gone to the doctor and spent more time talking about how to treat your symptoms, rather than what is causing them? Have you been prescribed medications that merely mask your symptoms, or even make them worse? Addressing the root cause...

6 months 3 weeks ago

Pages